-
SpinalCyte receives new regenerative medicine patents: 5 insights
SpinalCyte was issued new patents in the U.S. and Japan. -
New bone grafting policy includes Cerapedics' peptide enhanced bone graft — 3 insights
The International Society for the Advancement of Spine Surgery issued a new bone grafting policy that includes Cerapedics' i-FACTOR Peptide Enhanced Bone Graft. -
Aesculap Biologics reaches halfway mark in clinical trial for knee articular cartilage defects: 5 insights
Aesculap Biologics achieved 50 percent enrollment in its ongoing phase 3 clinical trial of Novocart 3D, an autologous chondrocyte transplantation system designed to treat articular cartilage defects of the knee. -
Global autologous matrix-induced chondrogenesis market to reach $186.4M by 2024 — 3 insights
The global autologous matrix-induced chondrogenesis market is expected to grow at an 8.6 percent compound annual growth rate by 2024, according to a Persistence Market Research report. -
Dr. Roger Hartl: The biggest opportunity in spinal biologics
Roger Hartl, MD, professor of neurological surgery and director of spine surgery at Weill Cornell Medicine in New York City, as well as director of the Weill Cornell Medicine Center for Comprehensive Spine Care, discusses the key trends in spine technology to consider in the future. -
Medtronic launches demineralized bone matrix for spine, orthopedics in Japan – 5 key notes
Medtronic launched Grafton Demineralized Bone Matrix for spine and orthopedic procedures in Japan. -
Cardinals' Carlos Martinez receives PRP injection at Andrews Institute for Orthopaedics and Sports Medicine — 4 insights
After reporting lingering shoulder pain, St. Louis Cardinals pitcher Carlos Martinez received a platelet-rich plasma injection at Gulf Breeze, Fla.-based Andrews Institute for Orthopaedics and Sports Medicine, the St. Louis Post-Dispatch reports. -
Dr. Daniel Birk's bold prediction: Spinal fusion will become mostly obsolete in 10 years
Daniel Birk, MD, director of the Neurosurgery Spine Center at Stony Brook (N.Y.) Medicine, discusses the biggest challenges and opportunities in spine device development today. -
1st case with KICVentures' company products in Latin America – 4 insights
Neurosurgeons Mario Cahueque, MD, and Enrique Azmitia, MD, performed SpineFrontier's first SacroFuse and NanoFUSE case in Latin America. -
Top 10 orthopedic biomaterial manufacturers
Here are the top manufacturers in the orthopedic biomaterials market, according to a Market Expertz report. -
3 thoughts on spine innovation from Dr. Andrew Cordover
Andrew Cordover, MD, a spine surgeon with Andrews Sports Medicine & Orthopaedic Center in Birmingham, Ala., discusses the key technology trends for 2019. -
Spinal biologics — Key areas of promising research and innovation
Andrew Hecht, MD, chief of spine surgery at The Mount Sinai Health System in New York City, outlines the key trends and big opportunities in the spine device space moving forward. -
5 surgeons using Lipogems
Here are five orthopedic and sports medicine surgeons using Lipogems, an FDA-cleared technology that uses the body's own adipose tissue to help heal injuries. -
SeaSpine and Kuros Biosciences sign bone graft agreement
Kuros Biosciences entered into a private label agreement with SeaSpine. -
Dr. Robert Watkins performs spine surgery with Osseus Fusion Systems' lateral technology: 4 key notes
Robert Watkins Jr., MD, performed his first surgery with the Osseus Fusion Systems Aries-L technology, which is currently in alpha launch. -
Michigan Medicine scientists aim to improve bone regeneration surgical technique: 5 things to know
Ann Arbor-based Michigan Medicine researchers are working to improve the Masquelet orthopedic surgical technique, according to MHealth Lab. -
Dr. Mark Miller on the risks of stem cell treatments for knee osteoarthritis
Mark Miller, MD, is an orthopedic sports medicine surgeon and orthopedic surgery professor at the University of Virginia in Charlottesville. -
Bone graft substitute receives CE mark approval: 3 notes
Sirakoss received CE mark approval for its Osteo3, a new nano-synthetic bone graft substitute designed for use in bone fracture repair. -
Dr. Seth Sherman performs cell-free knee cartilage repair implantation: 3 things to know about the FDA study
Seth L. Sherman, MD, enrolled and operated on four patients in a study of CartiHeal's Agili-C knee cartilage repair implant. -
Biogennix appoints new CFO: 5 things to know
Orthobiologics company Biogennix named Robert Bazier its new CFO.
Page 21 of 34